✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹0 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
-
PE
PE
-
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
3.35
ROCE (%)
ROCE (%)
5.34
Div Yield (%)
Div Yield (%)
-
Sales
Sales
1,372 Cr
OPM (%)
OPM (%)
0.17 %
Debt to Equity
Debt to Equity
0.00
About
Super Religare Laboratories Ltd offers the most comprehensive range of diagnostic facilities t… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

3 Neutral

Neutral for this company

2 No

Negative for this company

6 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Agilus Diagnostics Ltd. Business

Super Religare Laboratories Ltd offers the most comprehensive range of diagnostic facilities that cover an extensive range of specialties. Apart from pathology services SRL also provides a complete range of radiology modalities including Computed Tomography (CT), Diagnostic Radiology (X- Ray), Magnetic Resonance Imaging (MRI), Ultrasound and Positron Emission Tomography (“PET”).

Agilus Diagnostics major competitors are Jagsonpal Pharma, Hamps Bio, Rajnish Wellness, Smruthi Organics, IndoAmerican Advance, Acutaas Chemicals, Desh Rakshak Aushdh.
Market Cap of Agilus Diagnostics is ₹0 Crs.
While the median market cap of its peers are ₹136 Crs.

Agilus Diagnostics seems to be less financially stable compared to its competitors.
Altman Z score of Agilus Diagnostics is 0 and is ranked 7 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material